Skip to content

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
6.2×-1.0×
Amgen logo
AmgenAMGN
20.6×-6.3×
Gilead Sciences logo
Gilead SciencesGILD
7.4×+0.1×
Exelixis logo
ExelixisEXEL
5.8×+1.0×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
10.3×+7.2×
CG Oncology logo
CG OncologyCGON
5.2×+2.6×

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Market cap$4.55B+1,915%
Enterprise value$4.43B+2,204%
P/S79.9×+74.4×

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Calculated from Tango Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's price / book?
Tango Therapeutics (TNGX) reported price / book of 7.6× in Q1 2026.
How has Tango Therapeutics's price / book changed year-over-year?
Tango Therapeutics's price / book increased by 758.4% year-over-year, from 0.9× to 7.6×.
What is the long-term trend for Tango Therapeutics's price / book?
Over 5 years (2020 to 2025), Tango Therapeutics's price / book has grown at a -33.2% compound annual growth rate (CAGR), from 25.9× to 3.4×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.